Compared with advanced lung adenocarcinoma patients, the EGFR mutation rate of patients with lung squamous cell carcinoma (SCC) is much lower, about 4.2%-23.8% only (6–13). This evidence concerns the gene EGFR and squamous cell lung carcinoma.